SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (17648)1/11/1999 2:32:00 PM
From: VLAD  Read Replies (1) of 23519
 
martin,

The analysts have always been pulling numbers out of their ass.

How did they determine that there are 10 to 30 million men with ED? Did they do a door to door survey? You know there is a big difference between 10 million and 30 million. In essence they are saying that the market might be 10 million but it might be 3 times as big.

These are the same analysts who claimed that Pfizer was going to make 11 billion in Viagra's first year. I guess they were off by over 90%.

Bottom line is that it really doesn't matter how many impotent men there are. What matters is how many impotent men there are willing to try a safe local alternative to Viagra and how many PCPs are willing to offer MUSE as an alternative. So far it doesn't look like too many PCPs even know about MUSE. If they do they sure aren't offering it as an alternative.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News